Humacyte announces publication of new data on Symvess

Humacyte (HUMA) announced the publication of a new study comparing clinical outcomes of Symvess to autologous vein in the treatment of arterial trauma. The study was published in the American Association for the Surgery of Trauma’s Trauma Surgery & Acute Care Open Journal. The publication was entitled “Short-term Performance of Symvess Compared to External Control Data for Autologous Vein in Treatment of Extremity Arterial Trauma.” Compared to pre-existing patients in a trauma registry who were treated with autologous vein, patients treated with Symvess experienced similar short-term outcomes for patency, limb salvage, and infection.